3.
两组患者手术及术后病理情况
Surgical and pathological parameters
| Variables | Multiple nodules group (n=51) | Single nodule group (n=184) | P |
| Surgical methods | 0.000 | ||
| Wedge resection | 31 (60.8%) | 128 (69.6%) | |
| Wedge resection+Lobectomy | 15 (29.4%) | 13 (7.1%) | |
| Lobectomy | 3 (5.9%) | 36 (19.6%) | |
| Nodule removal | 2 (3.9%) | 7 (3.8%) | |
| Postoperative pathology | 0.416 | ||
| Invasive carcinoma | 15 (29.4%) | 73 (39.7%) | |
| Minimally invasive adenocarcinoma (MIA) | 7 (13.7%) | 39 (21.2%) | |
| Adenocarcinoma in situ (AIS) | 7 (13.7%) | 19 (10.3%) | |
| Atypical adenomatoid hyperplasia (AAH) | 7 (13.7%) | 16 (8.7%) | |
| Inflammatory nodules | 12 (23.5%) | 25 (13.6%) | |
| Sclerosing pneumocytoma | 0 | 3 (1.6%) | |
| Hamartoma | 2 (3.9%) | 6 (3.3%) | |
| Metastases | 1 (2.0%) | 3 (1.6%) |